All News
Updates on Psoriatic Arthritis at ACR 2018
I think 2018 was the year that belonged to psoriatic arthritis (although some may argue in favor of immune conditions induced by Checkpoint inhibitors). Many years ago the late Professor Verna Wright in Leeds (UK) was a lone voice for many years describing the clinical subtypes of Psoriatic arthritis as something distinctive from rheumatoid arthritis. For a long time we thought that the treatments for PsA were just the same as RA since we were treating the same problem of synovitis.
Read Article
The 16th Annual La Paulee
La Paulee is traditionally the party/feast after harvest and a time when hard work is rewarded with food, fun, and wine. And so it was that evening; after better understanding genes, cytokines, and pathology it was time to have a good time with friends, old and new.
Read Article
Checkpoint Inhibitor-related Myositis – Something Different
As expected, this year’s ACR meeting saw an upswing in the number of abstracts on immune related adverse events from checkpoint inhibitor therapy compared to last year.
Read Article
Links:
Dr. Rachel Tate uptoTate ( View Tweet)
Dr. John Cush RheumNow ( View Tweet)
ǝlʇʇıɥʍ ɯɐs samwhittle ( View Tweet)
Arthur Lau ArthurRheum ( View Tweet)
Arthur Lau ArthurRheum ( View Tweet)
Dr. John Cush RheumNow ( View Tweet)
Arthur Lau ArthurRheum ( View Tweet)
Arthur Lau ArthurRheum ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Paul Sufka, MD psufka ( View Tweet)
Links:
Dr. Rachel Tate uptoTate ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Emily Littlejohn ELittlejohnDO ( View Tweet)